|
|
Volumn 47, Issue 6, 2008, Pages 1863-1871
|
|
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ALANINE AMINOTRANSFERASE;
HEPATITIS B(E) ANTIGEN;
PLACEBO;
VIRUS DNA;
ADENINE;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
PHOSPHONIC ACID DERIVATIVE;
ADOLESCENT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
AREA UNDER THE CURVE;
ARTICLE;
CHILD;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
CREATININE BLOOD LEVEL;
DECOMPENSATED LIVER CIRRHOSIS;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
KIDNEY DYSFUNCTION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
SIDE EFFECT;
AGE;
BLOOD;
DOSE RESPONSE;
DRUG TOLERANCE;
ENZYMOLOGY;
GENETICS;
LIVER;
PRESCHOOL CHILD;
TREATMENT OUTCOME;
ADENINE;
ADOLESCENT;
AGE FACTORS;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DNA, VIRAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG TOLERANCE;
FEMALE;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
LIVER;
MALE;
PHOSPHONIC ACIDS;
TREATMENT OUTCOME;
|
|
EID: 46249118136
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.22250 Document Type: Article |
|
Times cited : (101)
|
|
References (8)
|
